Molecular mechanisms of preeclampsia
- 8 May 2007
- journal article
- review article
- Published by Elsevier in Microvascular Research
- Vol. 75 (1) , 1-8
- https://doi.org/10.1016/j.mvr.2007.04.009
Abstract
No abstract availableKeywords
This publication has 109 references indexed in Scilit:
- Endothelial DysfunctionHypertension, 2007
- Soluble Endoglin and Other Circulating Antiangiogenic Factors in PreeclampsiaNew England Journal of Medicine, 2006
- Agonistic Autoantibodies to the AT1 Receptor in a Transgenic Rat Model of PreeclampsiaHypertension, 2005
- Soluble vascular endothelial growth factor receptor-1 (sFlt-1) is increased throughout gestation in patients who have preeclampsia developAmerican Journal of Obstetrics and Gynecology, 2004
- Insulin Resistance and Alterations in AngiogenesisHypertension, 2004
- Circulating Angiogenic Factors and the Risk of PreeclampsiaNew England Journal of Medicine, 2004
- Differential Transcriptional Regulation of the Two Vascular Endothelial Growth Factor Receptor GenesJournal of Biological Chemistry, 1997
- Identification of a Natural Soluble Form of the Vascular Endothelial Growth Factor Receptor, FLT-1, and Its Heterodimerization with KDRBiochemical and Biophysical Research Communications, 1996
- Plasma of Preeclamptic Women Stimulates and Then Inhibits Endothelial ProstacyclinHypertension, 1996
- Inhibition of vascular endothelial cell growth factor activity by an endogenously encoded soluble receptor.Proceedings of the National Academy of Sciences, 1993